Cyberknife stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months.

Fiche publication


Date publication

août 2018

Journal

Journal of thoracic disease

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier


Tous les auteurs :
Khadige M, Salleron J, Marchesi V, Oldrini G, Peiffert D, Beckendorf V

Résumé

CyberKnife stereotactic radiotherapy allows for minimally invasive treatment with satisfactory results in patients with inoperable primary or metastatic lung cancer. The objective of this study was to identify factors influencing the probability of local control.

Mots clés

CyberKnife®, Real-time tracking, fiducial markers, stereotactic radiotherapy

Référence

J Thorac Dis. 2018 Aug;10(8):4976-4984